Sonoco Products (SON) recently had their rating decreased from Buy to Hold. Argus is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. Shares of SON fell by 1.61% or $-0.44/share to $26.90. In the past year, the shares have traded as low as $27.29 and as high as $36.95. On average, 628527 shares of SON exchange hands on a given day and today's volume is recorded at 551098.
JMP Securities, the brokerage firm, has recently changed the rating on Vertex Pharm (VRTX). They upped the rating from Mkt Perform to Mkt Outperform. The brokerage firm believes the company may be on the upswing and there could be potential value in buying the stock. The target price is currently set at $53 per share by the brokerage firm. Shares of VRTX traded higher by 1.58% or $0.64/share to $41.13. In the past year, the shares have traded as low as $32.08 and as high as $58.87. On average, 2117860 shares of VRTX exchange hands on a given day and today's volume is recorded at 2428319.
Rodman & Renshaw, the brokerage firm, has recently changed the rating on AMR (AMR). They upped the rating from Mkt Perform to Mkt Outperform. The brokerage firm believes the company may be on the upswing and there could be potential value in buying the stock. The target price is currently set at $5 per share by the brokerage firm. Shares of AMR traded higher by 17.68% or $0.35/share to $2.33. In the past year, the shares have traded as low as $1.75 and as high as $8.98. On average, 12838000 shares of AMR exchange hands on a given day and today's volume is recorded at 30451600.
Anadys Pharma (ANDS) recently had their rating increased from Mkt Perform to Mkt Outperform. JMP Securities is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bullish sign for the company's share price, as these brokerages begin to tell their clients to start buying the upgraded stock. The shares may see a continued uptrend because of this. Analysts believe that the company's share price may begin to improve. The target price is currently set at $3 per share by the brokerage firm. Shares of ANDS traded higher by 5.93% or $0.0486/share to $0.87. In the past year, the shares have traded as low as $0.60 and as high as $2.28. On average, 333283 shares of ANDS exchange hands on a given day and today's volume is recorded at 152762.
Omega Health (OHI) is currently being analyzed by the brokerage firm Stifel Nicolaus. They have just changed their rating from Hold to Buy. This indicates that the company may doing doing better than investors expect. Look for potential buying pressure or an upside move in the share price. The target price is currently set at $18 per share by the brokerage firm. Shares of OHI traded higher by 2.81% or $0.41/share to $15.01. In the past year, the shares have traded as low as $14.40 and as high as $24.46. On average, 1097780 shares of OHI exchange hands on a given day and today's volume is recorded at 2314677.
